INTELLISELECT
LIVE

Serial Number

97040176

Owner

Kymab Limited

Attorney

Karen Lim

Filing Date

Sep 22, 2021

Add to watchlist:

No watchlists yet
View on USPTO

INTELLISELECT Trademark

Serial Number: 97040176 • Registration: 7058471

INTELLISELECT is a trademark filed by Kymab Limited on September 22, 2021. The trademark is classified under Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

Kymab Limited (9 trademarks)

Babraham Research Campus
Cambridge CB22 3AT , GB

Entity Type: 99

Trademark Details

Filing Date

September 22, 2021

Registration Date

May 23, 2023

Published for Opposition

March 7, 2023

Goods & Services

Downloadable computer software for use in scientific and pharmaceutical research and development for identifying, creating or selecting antibody or antigen binding fragment thereof, or sequences and nucleic acids encoding them; downloadable computer software for scientific modelling antibodies and antigen binding fragment thereof; downloadable computer software for pharmaceutical modelling; downloadable computer software for research and development in the field of antibodies discovery

Pharmaceutical preparations for the prevention of diseases and disorders caused by bacteria; pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for the prevention of diseases of the immune system; preparations for detecting genetic predispositions for medical purposes; chemical preparations for medical use in DNA analysis; medicines for treating bacterial diseases and disorders, cancer, and immune-system diseases and disorders; vaccines; human vaccine preparations; vaccines for human use

Medical diagnostic testing, monitoring and reporting services; DNA screening for medical purposes; genetic analysis and reporting services for medical purposes in relation to the treatment of persons; medical services relating to DNA, genetics and genetic testing; genetic counselling

Research and development services in the medical and pharmaceuticals field of medicines, genetics, antibodies, oncology, immunology and inflammatory diseases and disorders; design and development of computer hardware and software; clinical research in the field of antibodies, oncology, immunology and inflammatory diseases and disorders; pharmaceutical research and development; development of pharmaceutical preparations and medicines; research and development services in the field of antibodies; structural and functional analysis of genomes; drug discovery services; laboratory research services relating to pharmaceuticals; providing medical and scientific research information in the fields of pharmaceuticals and genetics; research and development in the pharmaceutical and biotechnology fields; biotechnology testing and research to discover antibodies and pharmaceutical substances ; research in the field of medicines; research and development of vaccines and medicines; providing medical and scientific research information in the field of pharmaceuticals; medical research services; providing information in medical research concerning pharmaceutical substances

Filing History

NOTICE OF UPDATED REGISTRATION CONFIRMATION EMAILED
Apr 23, 2024 NURC
CORRECTION UNDER SECTION 7 - PROCESSED
Mar 15, 2024 COC.
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Mar 11, 2024 APRE
TEAS SECTION 7 REQUEST RECEIVED
Jul 18, 2023 ES7R
NOTICE OF REGISTRATION CONFIRMATION EMAILED
May 23, 2023 NRCC
REGISTERED-PRINCIPAL REGISTER
May 23, 2023 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 7, 2023 NPUB
PUBLISHED FOR OPPOSITION
Mar 7, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Feb 15, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Jan 26, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 21, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 21, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 21, 2022 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 23, 2022 GNRN
NON-FINAL ACTION E-MAILED
Jun 23, 2022 GNRT
NON-FINAL ACTION WRITTEN
Jun 23, 2022 CNRT
ASSIGNED TO EXAMINER
Jun 23, 2022 DOCK
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
Oct 28, 2021 AMPX
ASSIGNED TO LIE
Oct 28, 2021 ALIE
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Oct 25, 2021 NWOS
TEAS VOLUNTARY AMENDMENT RECEIVED
Oct 5, 2021 PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
Oct 4, 2021 PARI
NEW APPLICATION ENTERED
Sep 25, 2021 NWAP